Updated clinical results from German Real-World Registry demonstrate potential for Revita® to meaningfully sustain weight loss and lower blood sugar for at least one-year post-treatment in a real-world setting
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
FRACTYL HEALTH INC
NASDAQ:GUTS (2/7/2025, 8:00:01 PM)
After market: 1.5107 +0 (+0.05%)1.51
-0.1 (-6.21%)
GUTS Latest News and Analysis
15 hours ago - ChartmillWhat's going on in today's pre-market sessionDiscover the top movers in Friday's pre-market session and stay informed about market dynamics.
